atractylenolide iii has been researched along with chenodeoxycholic acid in 1 studies
| Studies (atractylenolide iii) | Trials (atractylenolide iii) | Recent Studies (post-2010) (atractylenolide iii) | Studies (chenodeoxycholic acid) | Trials (chenodeoxycholic acid) | Recent Studies (post-2010) (chenodeoxycholic acid) |
|---|---|---|---|---|---|
| 86 | 0 | 62 | 3,343 | 227 | 742 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liang, JW; Lin, HR; Tsai, CJ | 1 |
1 other study(ies) available for atractylenolide iii and chenodeoxycholic acid
| Article | Year |
|---|---|
Sesquiterpenoids from Atractylodes macrocephala act as farnesoid X receptor and progesterone receptor modulators.
Topics: Atractylodes; Cholesterol 7-alpha-Hydroxylase; Genes, Reporter; Hemorrhage; Hep G2 Cells; Humans; Hyperlipidemias; Hypolipidemic Agents; Luciferases; Plant Extracts; Promoter Regions, Genetic; Receptors, Cytoplasmic and Nuclear; Receptors, Progesterone; Sesquiterpenes; Transcriptional Activation; Transfection | 2012 |